HomeMDG1 • SWX
add
MediGene
Nakaraang pagsara
CHF 8.76
Sakop ng taon
CHF 8.76 - CHF 17.51
Market cap
16.95M EUR
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.46M | -6.00% |
Gastos sa pagpapatakbo | 5.22M | -0.04% |
Net na kita | -4.08M | -0.57% |
Net profit margin | -280.10 | -6.99% |
Kita sa bawat share | — | — |
EBITDA | -3.75M | 0.95% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 14.02M | -42.88% |
Kabuuang asset | 28.81M | -31.69% |
Kabuuang sagutin | 9.15M | -23.69% |
Kabuuang equity | 19.66M | — |
Natitirang share | 14.74M | — |
Presyo para makapag-book | 6.58 | — |
Return on assets | — | — |
Return on capital | -44.32% | — |
Cash Flow
Net change in cash
| (EUR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -4.08M | -0.57% |
Cash mula sa mga operasyon | -3.54M | 11.77% |
Cash mula sa pag-invest | 3.85M | 201.29% |
Cash mula sa financing | 2.36M | 2,998.77% |
Net change in cash | 2.68M | 194.29% |
Malayang cash flow | — | — |
Tungkol
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia
Itinatag
1994
Headquarters
Website
Mga Empleyado
87
